N6-methyladenosine Demethylase FTO Impairs Hepatic Ischemia–reperfusion Injury Via Inhibiting Drp1-mediated Mitochondrial Fragmentation

Ying Dong Du,Wen Yuan Guo,Cong Hui Han,Ying Wang,Xiao Song Chen,Da Wei Li,Jin Long Liu,Ming Zhang,Nan Zhu,Xin Wang

DOI: https://doi.org/10.1038/s41419-021-03622-x

2021-01-01

Cell Death and Disease

Abstract:Despite N6-methyladenosine (m6A) is functionally important in various biological processes, its role and the underlying regulatory mechanism in the liver remain largely unexplored. In the present study, we showed that fat mass and obesity-associated protein (FTO, an m6A demethylase) was involved in mitochondrial function during hepatic ischemia-reperfusion injury (HIRI). We found that the expression of m6A demethylase FTO was decreased during HIRI. In contrast, the level of m6A methylated RNA was enhanced. Adeno-associated virus-mediated liver-specific overexpression of FTO (AAV8-TBG-FTO) ameliorated the HIRI, repressed the elevated level of m6A methylated RNA, and alleviated liver oxidative stress and mitochondrial fragmentation in vivo and in vitro. Moreover, dynamin-related protein 1 (Drp1) was a downstream target of FTO in the progression of HIRI. FTO contributed to the hepatic protective effect via demethylating the mRNA of Drp1 and impairing the Drp1-mediated mitochondrial fragmentation. Collectively, our findings demonstrated the functional importance of FTO-dependent hepatic m6A methylation during HIRI and provided valuable insights into the therapeutic mechanisms of FTO.